To amend the Public Health Service Act with respect to the Silvio O. Conte Senior Biomedical Research Service.

Bill: 114-hr-2439
Sponsor: full_name: Rep. Collins, Chris [R-NY-27]
Introduced: 2015-05-19
Policy area: Health
Subjects: Department of Health and Human Services

Government employee pay, benefits, personnel management

Health personnel

Medical research

Research administration and funding
Latest action: action_date: 2015-05-22
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2015-05-19
action_desc: Introduced in House
text: <p>This bill amends the Public Health Service Act to revise the Silvio O. Conte Senior Biomedical Research Service to: (1) remove the limit on the number of members, (2) expand eligibility for appointment, (3) set a maximum pay rate, and (4) remove the option for members to contribute to the retirement system of an institution of higher education.</p> The Department of Health and Human Services must report on the implementation of these amendments, including whether the amendments improved the ability of the Food and Drug Administration to hire and retain qualified experts to fulfill obligations under user fee agreements.

tv_txt: I 114th CONGRESS 1st Session H. R. 2439 IN THE HOUSE OF REPRESENTATIVES May 19, 2015 Mr. Collins of New York introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Public Health Service Act with respect to the Silvio O. Conte Senior Biomedical Research Service.

1. Silvio O. Conte Senior Biomedical Research Service (a) Hiring and retention authority Section 228 of the Public Health Service Act ( 42 U.S.C. 237 ) is amended— (1) in the section heading, by inserting and Biomedical Product Assessment after Research ; (2) in subsection (a)(1), by striking Silvio O. Conte Senior Biomedical Research Service, not to exceed 500 members and inserting Silvio O. Conte Senior Biomedical Research and Biomedical Product Assessment Service (in this section referred to as the Service ), the purpose of which is to recruit and retain competitive and qualified scientific and technical experts outstanding in the field of biomedical research, clinical research evaluation, and biomedical product assessment ; (3) by amending subsection (a)(2) to read as follows: (2) The authority established in paragraph (1) may not be construed to require the Secretary to reduce the number of employees serving under any other employment system in order to offset the number of members serving in the Service. ; (4) in subsection (b)— (A) in the matter preceding paragraph (1), by striking or clinical research evaluation and inserting , clinical research evaluation or biomedical product assessment after evaluation ; and (B) in paragraph (1), by inserting or a master's level degree in engineering, bioinformatics, or a related or emerging field, after the comma; (5) in subsection (d), by striking and shall not exceed the rate payable for level I of the Executive Schedule unless approved by the President under section 5377(d)(2) of title 5, United States Code and inserting and shall not exceed the rate payable for the President ; (6) by striking subsection (e); and (7) by redesignating subsections (f) and (g) as subsections (e) and (f), respectively. (b) Report Not later than 3 years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit, and publish on the website of the Department of Health and Human Services a report on the implementation of the amendments made by subsection (a), including whether the amendments have improved the ability of the Food and Drug Administration to hire and retain qualified experts to fulfill obligations specified under user fee agreements.